Search research articles
Contact Us
Filters
Showing results (1-10 of 110) with videos related to
Page
of 11
Sort By:
Cancer Treatment Reviews
|
September 21, 2016
Clarification on Tartari et al.: Economic sustainability of anti-PD-1 agents nivolumab and pembrolizumab in cancer patients
Thomas Burke
JPMA. the Journal of the Pakistan Medical Association
|
July 31, 2013
Limited knee extension--a reliable indicator of a successful closed reduction of developmental dysplasia of hip
Nabeel Dastgir, Thomas Burke
Science (New York, N.Y.)
|
June 10, 2017
The dishonest HONEST Act
David Michaels, Thomas Burke
Gynecologic Oncology
|
December 23, 2008
New membership model
Thomas Burke, Eva Chalas
The New England Journal of Medicine
|
December 29, 2018
Heat-Stable Carbetocin to Prevent Postpartum Hemorrhage
Deborah Armbruster, Thomas Burke, Andrew Weeks
Pharmacoeconomics - Open
|
July 22, 2021
Cost-Minimization Analysis of Pembrolizumab Monotherapy Versus Nivolumab in Combination with Ipilimumab as First-Line Treatment for Metastatic PD-L1-Positive Non-small Cell Lung Cancer: A US Payer Perspective
Nan Qiao, Ralph Insinga, Thomas Burke, et al.
Molecular and Biochemical Parasitology
|
March 16, 2010
Development of a screen to dissect Toxoplasma gondii egress
Keith P Eidell, Thomas Burke, Marc-Jan Gubbels
Scientific Reports
|
April 29, 2021
Real-world outcomes of first-line pembrolizumab plus pemetrexed-carboplatin for metastatic nonsquamous NSCLC at US oncology practices
Vamsidhar Velcheti, Xiaohan Hu, Bilal Piperdi, et al.
Consciousness and Cognition
|
November 13, 2025
Working with an Online Artificial Partner Enhances Implicit and Reduces Explicit Sense of Agency
Anh H Le, Thomas Burke, Andrew P Bayliss
Journal of Public Health Management and Practice : JPHMP
|
December 20, 2007
Examining the front lines of local environmental public health practice: a Maryland case study
Beth Resnick, Joanna Zablotsky, Keeve Nachman, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 110) with videos related to
Sort By:
Page
of 11
Cancer Treatment Reviews
|
September 21, 2016
Clarification on Tartari et al.: Economic sustainability of anti-PD-1 agents nivolumab and pembrolizumab in cancer patients
Thomas Burke
JPMA. the Journal of the Pakistan Medical Association
|
July 31, 2013
Limited knee extension--a reliable indicator of a successful closed reduction of developmental dysplasia of hip
Nabeel Dastgir, Thomas Burke
Science (New York, N.Y.)
|
June 10, 2017
The dishonest HONEST Act
David Michaels, Thomas Burke
Gynecologic Oncology
|
December 23, 2008
New membership model
Thomas Burke, Eva Chalas
The New England Journal of Medicine
|
December 29, 2018
Heat-Stable Carbetocin to Prevent Postpartum Hemorrhage
Deborah Armbruster, Thomas Burke, Andrew Weeks
Pharmacoeconomics - Open
|
July 22, 2021
Cost-Minimization Analysis of Pembrolizumab Monotherapy Versus Nivolumab in Combination with Ipilimumab as First-Line Treatment for Metastatic PD-L1-Positive Non-small Cell Lung Cancer: A US Payer Perspective
Nan Qiao, Ralph Insinga, Thomas Burke, et al.
Molecular and Biochemical Parasitology
|
March 16, 2010
Development of a screen to dissect Toxoplasma gondii egress
Keith P Eidell, Thomas Burke, Marc-Jan Gubbels
Scientific Reports
|
April 29, 2021
Real-world outcomes of first-line pembrolizumab plus pemetrexed-carboplatin for metastatic nonsquamous NSCLC at US oncology practices
Vamsidhar Velcheti, Xiaohan Hu, Bilal Piperdi, et al.
Consciousness and Cognition
|
November 13, 2025
Working with an Online Artificial Partner Enhances Implicit and Reduces Explicit Sense of Agency
Anh H Le, Thomas Burke, Andrew P Bayliss
Journal of Public Health Management and Practice : JPHMP
|
December 20, 2007
Examining the front lines of local environmental public health practice: a Maryland case study
Beth Resnick, Joanna Zablotsky, Keeve Nachman, et al.
Page
of 11